Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Conference Spotlight

Russian Inspectorate Weighs in on Remote Audits and International Harmonization

No items found.
Conference Spotlight

FDA Combination Products Policy and Guidance Changes

No items found.
Enforcement

OTC Skincare Firm Receives Warning Letter Due to CGMP Concerns

No items found.

New Year, New Enforcement Analytics

No items found.
Conference Spotlight

FDA OMQ Regulatory Actions Increase Dramatically in FY2020

No items found.

Our Top 5 Webinars of 2020

No items found.

Our Top 5 Articles of 2020

No items found.

Overcoming CMC Complexity for Cell & Gene Products

No items found.

Ashley Boam on FDA’s Proposed Quality Maturity Model

No items found.

Redica Announces Addition of Jason Kerr

No items found.
Conference Spotlight

Latest Chinese Pharmacopoeia Includes Updated Chapters in Key Areas

No items found.
Conference Spotlight

FDA’s Vision for the Future of Biomanufacturing

No items found.
Conference Spotlight

89 Products Filed as NDAs Now BLAs Under Regulation Change

No items found.

Redica Systems Welcomes Chelsey Langan

No items found.
Conference Spotlight

Overcoming the Quality Challenges of a CAR-T Cell Product: One Company’s Experience

No items found.
Conference Spotlight

Impact of Brexit on UK & Northern Ireland Medical Device Regulations

No items found.
Enforcement

FDA Warning Letters: 11/22/2020 & 12/1/2020

No items found.
Conference Spotlight

FDA Cracks Down on Unapproved HCT Products

No items found.